0001104659-21-136408.txt : 20211109 0001104659-21-136408.hdr.sgml : 20211109 20211109174030 ACCESSION NUMBER: 0001104659-21-136408 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211109 FILED AS OF DATE: 20211109 DATE AS OF CHANGE: 20211109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kirsch Arthur S CENTRAL INDEX KEY: 0001290976 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37841 FILM NUMBER: 211393501 MAIL ADDRESS: STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101 STREET 2: C/O ARALEZ PHARMACEUTICALS INC. CITY: MISSISSAUGA STATE: A6 ZIP: L5N 0E4 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kadmon Holdings, Inc. CENTRAL INDEX KEY: 0001557142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273576929 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 450 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 833-900-5366 MAIL ADDRESS: STREET 1: 450 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: Kadmon Holdings, LLC DATE OF NAME CHANGE: 20120829 4 1 tm2131118-8_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-11-09 1 0001557142 Kadmon Holdings, Inc. KDMN 0001290976 Kirsch Arthur S C/O KADMON HOLDINGS, INC. 450 E. 29TH STREET NEW YORK NY 10016 1 0 0 0 Common Stock 2021-11-09 4 D 0 30000 9.50 D 0 D Stock Option (right to buy) 2.29 2021-11-09 4 D 0 64103 7.21 D 2029-05-15 Common Stock, par value $0.001 64103 0 D Stock Option (right to buy) 2.29 2021-11-09 4 D 0 100000 7.21 D 2029-05-15 Common Stock, par value $0.001 100000 0 D Stock Option (right to buy) 4.44 2021-11-09 4 D 0 85034 5.06 D 2030-05-13 Common Stock, par value $0.001 85034 0 D Stock Option (right to buy) 3.58 2021-11-09 4 D 0 96975 5.92 D 2031-05-12 Common Stock, par value $0.001 96975 0 D Disposed pursuant to the acquisition by Sanofi of the entire issued share capital of Issuer on November 9, 2021 by means of a plan of merger (the "Merger"). In connection with the Merger, all unvested stock options ("Options") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option. Represents the payment per share of Common Stock received in exchange for the cancellation of each Option. /s/ Gregory S. Moss, Attorney-in-Fact 2021-11-09